Jim Cramer Reveals Details Of Trump’s Tariff Negotiations & Discusses 10 Stocks

5. Johnson & Johnson (NYSE:JNJ)

Number of Hedge Fund Holders In Q4 2024: 98

Johnson & Johnson (NYSE:JNJ) is a well-known healthcare company. The tariff-induced selloff in growth stocks and in those that have exposure to China has translated into tailwinds for the firm. Johnson & Johnson (NYSE:JNJ)’s shares are up by 7.9% year-to-date as investors have flocked to firms with domestic US exposure. In his previous comments about the firm, Cramer said that the market is operating in a forgiving environment for Johnson & Johnson (NYSE:JNJ). Here are his latest thoughts:

“You said it yourself like JNJ, the thing that. . .didn’t save their quarter, but what made it so that you kind of liked it is the weak dollar. So remember most of these companies are like wow, bring it down . . . the companies themselves are very pro weak dollar. So when you speak to them offline, they love it.”